International Clinical Trial: A Controlled Clinical Study on D-TACE Combined with Molecular Targeted Drugs and Immune Checkpoint Inhibitors with or Withouts Hepatic Artery Infusion Therapy for Large Hepatocellular Carcinoma

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123054) titled 'A Controlled Clinical Study on D-TACE Combined with Molecular Targeted Drugs and Immune Checkpoint Inhibitors with or Withouts Hepatic Artery Infusion Therapy for Large Hepatocellular Carcinoma' on April 21.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Fujian Cancer Hospital

Condition: Hepatocellular Carcinoma

Intervention: Group A:D-TACE combined with continuous hepatic arterial infusion chemotherapy and first-line systemic therapy

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-01

Target Sample Size: Group A:60;Group B:60;

Countries of Re...